Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
55.31
+0.48 (0.88%)
Nov 21, 2024, 12:54 PM EST - Market open
Soleno Therapeutics Market Cap
Soleno Therapeutics has a market cap or net worth of $2.38 billion as of November 21, 2024. Its market cap has increased by 932.84% in one year.
Market Cap
2.38B
Enterprise Value
2.08B
1-Year Change
932.84%
Ranking
Category
Stock Price
$55.31
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $2.38B, an increase of 9,555.16%. That is a compound annual growth rate of 57.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.23B | 81.91% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeMaitre Vascular | 2.33B |
| CG Oncology | 2.30B |
| Geron | 2.29B |
| NewAmsterdam Pharma Company | 2.28B |
| IDEAYA Biosciences | 2.26B |
| Keros Therapeutics | 2.19B |
| CONMED | 2.19B |
| Premier | 2.15B |